{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:44:30Z","timestamp":1781041470462,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21\\u2013831381-C"],"award-info":[{"award-number":["-21\\u2013831381-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["#ADSF-24\\u20131284328-C"],"award-info":[{"award-number":["#ADSF-24\\u20131284328-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21\\u2013831376-C"],"award-info":[{"award-number":["-21\\u2013831376-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21\\u2013831377-C"],"award-info":[{"award-number":["-21\\u2013831377-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","award":["3730164"],"award-info":[{"award-number":["3730164"]}],"id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022\\u201301018"],"award-info":[{"award-number":["2022\\u201301018"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019\\u201302397"],"award-info":[{"award-number":["2019\\u201302397"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023\\u201300356"],"award-info":[{"award-number":["2023\\u201300356"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003189","name":"Freemasons New Zealand","doi-asserted-by":"publisher","award":["3707314"],"award-info":[{"award-number":["3707314"]}],"id":[{"id":"10.13039\/501100003189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003189","name":"Freemasons New Zealand","doi-asserted-by":"publisher","award":["3726531"],"award-info":[{"award-number":["3726531"]}],"id":[{"id":"10.13039\/501100003189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021\\u201300694"],"award-info":[{"award-number":["JPND2021\\u201300694"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014191","name":"The University of Auckland Brain Research New Zealand","doi-asserted-by":"publisher","award":["3715325"],"award-info":[{"award-number":["3715325"]}],"id":[{"id":"10.13039\/501100014191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014191","name":"The University of Auckland Brain Research New Zealand","doi-asserted-by":"publisher","award":["371556"],"award-info":[{"award-number":["371556"]}],"id":[{"id":"10.13039\/501100014191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809\\u20132016862"],"award-info":[{"award-number":["201809\\u20132016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neurobiolaging.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:02:01Z","timestamp":1745607721000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep: Potential implications for therapeutic targets in Alzheimer's disease"],"prefix":"10.1016","volume":"152","author":[{"given":"Natasha E.","family":"Mckean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skye R.","family":"Rudiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"McLaughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Gusella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee H.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg T.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Heslegrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Veleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon","family":"Laban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Bawden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-4014","authenticated-orcid":false,"given":"Russell G.","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2025.04.006_bib1","unstructured":"ALZFORUM, 2024. MUTATIONS. (Accessed 07\/02\/2024 2024)."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.04.006_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ceb.2004.03.003","article-title":"Nonsense-mediated mRNA decay: terminating erroneous gene expression","volume":"16","author":"Baker","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.04.006_bib3","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1021\/bi015810h","article-title":"Endoproteolysis of presenilin in vitro: inhibition by \u03b3-secretase inhibitors","volume":"41","author":"Campbell","year":"2002","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/nbdi.2002.0542","article-title":"Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12","volume":"11","author":"Chan","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.04.006_bib5","first-page":"1","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","author":"Chen","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular Med"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.04.006_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0896-6273(00)80998-8","article-title":"An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos","volume":"20","author":"Davis","year":"1998","journal-title":"Neuron"},{"issue":"6727","key":"10.1016\/j.neurobiolaging.2025.04.006_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/19083","article-title":"A presenilin-1-dependent \u03b3-secretase-like protease mediates release of Notch intracellular domain","volume":"398","author":"De Strooper","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2025.04.006_bib9","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","article-title":"Aducanumab: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.04.006_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0896-6273(00)80232-9","article-title":"Protein topology of presenilin 1","volume":"17","author":"Doan","year":"1996","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.04.006_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0896-6273(01)00523-2","article-title":"Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces","volume":"32","author":"Feng","year":"2001","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.04.006_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5800","key":"10.1016\/j.neurobiolaging.2025.04.006_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2025.04.006_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcdb.2020.05.019","article-title":"The substrate repertoire of \u03b3-secretase\/presenilin","volume":"105","author":"G\u00fcner","year":"2020","journal-title":"Semin Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.04.006_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal","volume":"9","author":"Hardy","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"5054","key":"10.1016\/j.neurobiolaging.2025.04.006_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.neurobiolaging.2025.04.006_bib17","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.neurobiolaging.2025.04.006_bib18","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.96.21.11872","article-title":"Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency","volume":"96","author":"Herreman","year":"1999","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.04.006_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.04.006_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neurobiolaging.2003.09.008","article-title":"APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1","volume":"25","author":"Jankowsky","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-2010-1360","article-title":"Presenilin-1 holoprotein is an interacting partner of sarco endoplasmic reticulum calcium-ATPase and confers resistance to endoplasmic reticulum stress","volume":"20","author":"Jin","year":"2010","journal-title":"J. Alzheimer'S. Dis."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.04.006_bib23","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.theriogenology.2004.09.010","article-title":"Enhanced efficiency in the production of offspring from 4-to 8-week-old lambs","volume":"63","author":"Kelly","year":"2005","journal-title":"Theriogenology"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.04.006_bib24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1071\/RD07093","article-title":"Effect of GnRH treatment on the maturation and in vitro development of oocytes collected from 4-to 6-week-old Merino lambs","volume":"19","author":"Kelly","year":"2007","journal-title":"Reprod. Fertil. Dev."},{"issue":"6860","key":"10.1016\/j.neurobiolaging.2025.04.006_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35102669","article-title":"Sheep don't forget a face","volume":"414","author":"Kendrick","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.04.006_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","article-title":"Diagnosis of Alzheimer's disease","volume":"42","author":"Khachaturian","year":"1985","journal-title":"Arch. Neurol."},{"issue":"4863","key":"10.1016\/j.neurobiolaging.2025.04.006_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/197192b0","article-title":"Paired helical filaments in electron microscopy of Alzheimer's disease","volume":"197","author":"Kidd","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2025.04.006_bib28","volume":"401","author":"Kinoshita","year":"2007","journal-title":"Alzforum"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2011.03.022","article-title":"Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome?","volume":"21","author":"Larner","year":"2011","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.04.006_bib30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.410400604","article-title":"Genetic factors in Alzheimer's disease: a review of recent advances","volume":"40","author":"Levy-Lahad","year":"1996","journal-title":"Ann. Neurol."},{"issue":"18","key":"10.1016\/j.neurobiolaging.2025.04.006_bib31","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","article-title":"Minimap2: pairwise alignment for nucleotide sequences","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib32","first-page":"31","article-title":"Polymorphisms of presenilin-1 gene associate with dilated cardiomyopathy susceptibility","volume":"358","author":"Li","year":"2011","journal-title":"Mol. Cell Biochem"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.04.006_bib33","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1086\/509900","article-title":"Mutations of presenilin genes in dilated cardiomyopathy and heart failure","volume":"79","author":"Li","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/156802608783334060","article-title":"Activity of gamma-secretase on substrates other than APP","volume":"8","author":"Lleo","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.04.006_bib35","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2174\/156802611795861004","article-title":"\u03b3-secretase substrates and their implications for drug development in Alzheimer's disease","volume":"11","author":"Lleo","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"24","key":"10.1016\/j.neurobiolaging.2025.04.006_bib36","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1074\/jbc.M115.708297","article-title":"Presenilin 1 and presenilin 2 target \u03b3-secretase complexes to distinct cellular compartments","volume":"291","author":"Meckler","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-4827(03)00257-X","article-title":"Developmental control of Presenilin1 expression, endoproteolysis, and interaction in zebrafish embryos","volume":"289","author":"Nornes","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","article-title":"Regulation of APP cleavage by \u03b1-, \u03b2-and \u03b3-secretases","volume":"483","author":"Nunan","year":"2000","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.04.006_bib39","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. protoc."},{"key":"10.1016\/j.neurobiolaging.2025.04.006_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2017.06.020","article-title":"Alzheimer's disease markers in the aged sheep (Ovis aries)","volume":"58","author":"Reid","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.04.006_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2016.05.020","article-title":"Restricted location of PSEN2\/\u03b3-secretase determines substrate specificity and generates an intracellular A\u03b2 pool","volume":"166","author":"Sannerud","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.04.006_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","article-title":"Skeletal and CNS defects in Presenilin-1-deficient mice","volume":"89","author":"Shen","year":"1997","journal-title":"Cell"},{"issue":"6534","key":"10.1016\/j.neurobiolaging.2025.04.006_bib44","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.04.006_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"issue":"6930","key":"10.1016\/j.neurobiolaging.2025.04.006_bib46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature01506","article-title":"The role of presenilin cofactors in the gamma-secretase complex","volume":"422","author":"Takasugi","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.04.006_bib47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3233\/JAD-231297","article-title":"Impaired skeletal development by disruption of presenilin-1 in pigs and generation of novel pig models for Alzheimer\u2019s disease","volume":"101","author":"Uh","year":"2024","journal-title":"J. Alzheimer'S. Dis."},{"issue":"6007","key":"10.1016\/j.neurobiolaging.2025.04.006_bib48","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"\u03b3-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"48","key":"10.1016\/j.neurobiolaging.2025.04.006_bib49","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1523\/JNEUROSCI.3261-14.2014","article-title":"Partial loss of presenilin impairs age-dependent neuronal survival in the cerebral cortex","volume":"34","author":"Watanabe","year":"2014","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.04.006_bib50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100013949","article-title":"Early-onset familial Alzheimer's disease (EOFAD)","volume":"39","author":"Wu","year":"2012","journal-title":"Can. J. Neurol. Sci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:05:46Z","timestamp":1778565946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S0197458025000752"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.04.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep: Potential implications for therapeutic targets in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}